SIL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.526400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.482800E-01
Normal-vs-Stage2
3.236800E-01
Normal-vs-Stage3
4.247200E-01
Normal-vs-Stage4
3.880000E-01
Stage1-vs-Stage2
2.804400E-01
Stage1-vs-Stage3
3.537200E-01
Stage1-vs-Stage4
2.164800E-01
Stage2-vs-Stage3
9.026800E-01
Stage2-vs-Stage4
6.882400E-01
Stage3-vs-Stage4
7.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.745600E-01
Normal-vs-AfricanAmerican
2.833200E-01
Normal-vs-Asian
1.062560E-01
Caucasian-vs-AfricanAmerican
7.081000E-01
Caucasian-vs-Asian
4.695200E-01
AfricanAmerican-vs-Asian
2.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.828000E-01
Normal-vs-Female
2.549600E-01
Male-vs-Female
2.423600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.253200E-01
Normal-vs-Age(41-60Yrs)
4.427200E-01
Normal-vs-Age(61-80Yrs)
2.036200E-01
Normal-vs-Age(81-100Yrs)
6.205800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.739600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.973400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.066400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.232000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.310000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.065990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.577170E-01
Normal-vs-Daily Drinker
4.090800E-01
Normal-vs-Weekly Drinker
2.477700E-02
Normal-vs-Occasional Drinker
5.851200E-01
Normal-vs-Social Drinker
2.144800E-01
Non Drinker-vs-Daily Drinker
5.089000E-01
Non Drinker-vs-Weekly Drinker
4.243000E-01
Non Drinker-vs-Occasional Drinker
7.919400E-01
Non Drinker-vs-Social Drinker
7.079600E-01
Daily Drinker-vs-Weekly Drinker
8.054200E-01
Daily Drinker-vs-Occasional Drinker
8.574200E-01
Daily Drinker-vs-Social Drinker
4.045800E-01
Weekly Drinker-vs-Occasional Drinker
9.750600E-01
Weekly Drinker-vs-Social Drinker
2.522200E-01
Occasional Drinker-vs-Social Drinker
6.881400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.211200E-01
Normal-vs-Grade 2
6.986200E-01
Normal-vs-Grade 3
9.790400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.183600E-01
Grade 1-vs-Grade 3
5.916000E-02
Grade 1-vs-Grade 4
6.211200E-01
Grade 2-vs-Grade 3
7.104400E-02
Grade 2-vs-Grade 4
6.986200E-01
Grade 3-vs-Grade 4
9.790400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.051200E-01
Normal-vs-NonDiabetic
2.806000E-01
Diabetic-vs-NonDiabetic
7.570200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.660300E-02
Normal-vs-NoPancreatitis
3.133400E-01
Pancreatitis-vs-NoPancreatitis
7.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.500580E-01
Normal-vs-N1
3.588400E-01
N0-vs-N1
7.645600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.321200E-01
Normal-vs-TP53-NonMutant
4.383600E-01
TP53-Mutant-vs-TP53-NonMutant
3.271900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
